newsThe committee’s approval of the one-time gene therapy means the…
31 January 2025 | By Catherine Eckford (European Pharmaceutical Review)
The committee’s approval of the one-time gene therapy means the healthcare inequalities for patients with this genetic blood disorder can begin to be re-addressed.
